Quest Diagnostics | DGX - Cash And Equivalent


Quest Diagnostics reported $626M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Acadia Healthcare USD 158.47M 25.23M Mar/2026
Agilent USD 1.81B 49M Mar/2026
Baxter International USD 2.15B 133M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Centene USD 24.15B 2.89B Jun/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Cigna USD 6.3B 742M Jun/2026
Community Health Systems USD 149M 563M Jun/2026
Concord Medical Services Hldg CNY 243.38M 85.1M Jun/2023
CVS Health USD 11.33B 1.79B Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
DaVita Healthcare Partners USD 668.96M 24.72M Jun/2026
Elevance Health USD 10.23B 575M Jun/2026
Encompass Health USD 107.7M 2.8M Jun/2026
HCA USD 940M 100M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Humana USD 6.89B 1.94B Jun/2026
Illumina USD 1.09B 329M Mar/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Laboratory Of America USD 141.8M 839.3M Jun/2026
McKesson USD 5.16B 1.19B Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Molina Healthcare USD 4.99B 329M Jun/2026
Owens Minor USD 336.88M 54.89M Mar/2026
Pediatrix Medical Group USD 288.88M 83.1M Jun/2026
Quest Diagnostics USD 626M 233M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Tenet Healthcare USD 2.17B 797M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
UnitedHealth USD 31.47B 239M Jun/2026
Universal Health Services USD 138.8M 19.77M Jun/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 539M 77M Jun/2026
Zoetis USD 1.48B 465M Jun/2026